Leonid Poretsky

Dr. Leonid Poretsky

orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 November 2018 in Molecular Medicine
Verified
Journal Article
Open access
PDF file
SFSarah Louise Fishman
Sarah Louise Fishman
HSHalis Sonmez
Halis Sonmez
CBCraig Basman
Craig Basman
VSVarinder Singh
Varinder Singh
LPLeonid Poretsky
Leonid Poretsky
Traditional risk factors are insufficient to explain all cases of coronary artery disease (CAD) in patients with diabetes mellitus (DM). Advanced glycation end-products (AGEs) and their receptors may play important roles in the development and progression of CAD. Hyperglycemia is the hallmark feature of DM. An increase in the incidence of both micro-and macrovascular complications of diabetes has been observed with increased duration of hyperglycemia. This association persists even after glycemic control has been achieved, suggesting an innate mechanism of “metabolic memory.” AGEs are glycated proteins that may serve as mediators of metabolic memory due to their increased production in the setting of hyperglycemia and generally slow turnover. Elevated AGE levels can lead to abnormal cross linking of extracellular and intracellular proteins disrupting their normal structure and function. Furthermore, activation of AGE receptors can induce complex signaling pathways leading to increased inflammation, oxidative stress, enhanced calcium deposition, and increased vascular smooth muscle apoptosis, contributing to the development of atherosclerosis. Through these mechanisms, AGEs may be important mediators of the development of CAD. However, clinical studies regarding the role of AGEs and their receptors in advancing CAD are limited, with contradictory results. AGEs and their receptors may be useful biomarkers for the presence and severity of CAD. Further studies are needed to evaluate the utility of circulating and tissue AGE levels in identifying asymptomatic patients at risk for CAD or to identify patients who may benefit from invasive intervention.

3 March 2022 in Metabolism Open
Verified
Journal Article
Open access
NSNyein Chan Swe
Nyein Chan Swe
SASamihah Ahmed
Samihah Ahmed
MEMarwen Eid
Marwen Eid
LPLeonid Poretsky
Leonid Poretsky
EGEugenia Gianos
Eugenia Gianos
NCNatalie E. Cusano
Natalie E. Cusano
Approximately 1.5 million people in the United States currently identify as transgender. The use of gender affirming hormone therapy is integral to routine clinical care of transgender individuals, yet our understanding of the effects of this therapy is limited. There are reasons to believe that gender affirming hormone therapy may have important effects on cardiovascular risk and bone health in transgender individuals. The purpose of this review article is to summarize the evidence for the cardiovascular effects (including coronary artery disease, hypertension and stroke) as well as the effects on bone metabolism associated with gender affirming hormone therapy in both transgender men and transgender women.

1 September 2017 in Reproductive Biology
Verified
Journal Article
Closed access
LPLeonid Poretsky
Leonid Poretsky
JIJulie Islam
Julie Islam
Dimiter AvtanskiDimiter Avtanski
Dimiter Avtanski
YLYu Kuei Lin
Yu Kuei Lin
YSYi-Ling Shen
Yi-Ling Shen
DSDonna Seto-Young
Donna Seto-Young

1 August 2006 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
LPLeonid Poretsky
Leonid Poretsky
IT HAS BEEN proposed recently that polycystic ovary syndrome (PCOS) develops as a result of increased ovarian sensitivity to insulin (1). Although there is evid

13 January 2023 in Metabolism Open
Verified
Journal Article
Open access
LPLeonid Poretsky
Leonid Poretsky
AYArielle Yeshua
Arielle Yeshua
TCTal Cantor
Tal Cantor
DADimiter Avtanski
Dimiter Avtanski
Radoslav StojchevskiRadoslav Stojchevski
Radoslav Stojchevski
TSTomer Singer
Tomer Singer
Reproduction and energy metabolism are closely related, and fertility can be directly affected by either obesity or malnutrition. In this study, we investigated the in vitro effects of irisin and leptin, two hormones primarily involved in energy metabolism, on the expression of genes encoding key steroidogenic enzymes in primary cultures of human granulosa cells. Granulosa cells were purified from follicular fluid samples obtained during in vitro fertilization (IVF) procedure, cultured, and treated with irisin (125-2000 ng/ml) or leptin (25-400 ng/ml) for 1-3 days. mRNA expression levels of cytochrome P450 enzymes [CYP11A1, CYP19A1, CYP21A2], hydroxy-delta-5-steroid dehydrogenase, 3 beta and steroid delta-isomerase 1 (HSD3B1), and hydroxysteroid 17-beta dehydrogenase 3 (HSD17B3) were measured using qRT-PCR analysis. Irisin significantly upregulated CYP19A1 mRNA levels, while leptin upregulated CYP19A1 and HSD3B1 mRNA levels. These preliminary results show that irisin and leptin may directly affect the expression of the genes important for ovarian steroidogenesis and female reproduction.

1 August 2019 in Data in Brief
Verified
Journal Article
Open access
Dimiter AvtanskiDimiter Avtanski
Dimiter Avtanski
AGAnabel Garcia
Anabel Garcia
BCBeatriz Caraballo
Beatriz Caraballo
PTPriyanthan Thangeswaran
Priyanthan Thangeswaran
SMSela Marin
Sela Marin
LPLeonid Poretsky
Leonid Poretsky
Resistin is an adipokine produced by the white adipocytes and adipose-derived macrophages, which mediates inflammation and insulin resistance Huang et al., 1997 and Renehan et al., 2008 Feb. Here, we provide data on the effect of resistin on epithelial to mesenchymal transition (EMT) in breast cancer cells in vitro. As model systems, we used human MCF-7 (low-metastatic) and MDA-MB-231 (high-metastatic) breast cancer cell lines. To optimize experimental conditions, we treated the cells with various concentrations of resistin (12.5, 25 and 50 ng/ml) for different time intervals (6 and 24 hours), and measured SOCS3 mRNA expression by using qRT-PCR analysis. Further, we used qRT-PCR and Western blot analyses to measure the expression of various epithelial (E-cadherin, claudin-1) and mesenchymal (SNAIL, SLUG, ZEB1, TWIST1, fibronectin, and vimentin) markers after resistin treatment. This data article is part of a study Avtanski et al., 2019 May, where detailed interpretation and discussion can be found.